Alarming increase in fluoroquinolone resistance among non-typhoidal salmonella isolates

We aimed to describe the evolution of fluoroquinolone resistance rates among non-typhoidal Salmonella (NTS) isolated from clinical specimens. Data from the patients who were admitted to Vehbi Koç Foundation Health Institutions (Koç University Hospital, American Hospital, and American Medical Centres in Istanbul and Bodrum) with enteritis or fever symptoms between January 1, 2020, and September 30, 2023, and whose clinical specimens revealed various NTS serovars were assessed in this study. A total of 387 NTS isolates were included. For repeated isolates, the first isolate from a patient within 1 year was included.